This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Jan 24;13(1):10-12.

doi: 10.4103/idoj.idoj_2_22. eCollection 2022 Jan-Feb.

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint

Nusrat Shafiq¹, Samiksha Bhattacharjee¹, Samir Malhotra¹

Affiliations

PMID: 35198462
PMCID: PMC8809142
DOI: 10.4103/idoj.idoj_2_22

Editorial

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists' Viewpoint

Nusrat Shafiq et al. Indian Dermatol Online J. 2022.

. 2022 Jan 24;13(1):10-12.

doi: 10.4103/idoj.idoj_2_22. eCollection 2022 Jan-Feb.

Authors

Nusrat Shafiq¹, Samiksha Bhattacharjee¹, Samir Malhotra¹

Affiliation

¹ Department of Pharmacology, Clinical Pharmacology Unit, PGIMER, Chandigarh, India.

PMID: 35198462
PMCID: PMC8809142
DOI: 10.4103/idoj.idoj_2_22

No abstract available

PubMed Disclaimer

Similar articles

Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?
Erdeljić V, Francetić I, Makar-Ausperger K, Likić R, Radacić-Aumiler M. Erdeljić V, et al. Eur J Clin Pharmacol. 2010 Oct;66(10):1037-46. doi: 10.1007/s00228-010-0867-5. Epub 2010 Jul 20. Eur J Clin Pharmacol. 2010. PMID: 20644922
Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting.
Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA. Taegtmeyer AB, et al. Br J Clin Pharmacol. 2011 Dec;72(6):958-64. doi: 10.1111/j.1365-2125.2011.04032.x. Br J Clin Pharmacol. 2011. PMID: 21627677 Free PMC article.
Pharmacologists' participation in teaching hospitals for shaping future clinical research in India.
Imran M. Imran M. Perspect Clin Res. 2012 Oct;3(4):149-50. doi: 10.4103/2229-3485.103600. Perspect Clin Res. 2012. PMID: 23293766 Free PMC article. No abstract available.
Phase III trials: specific problems associated with the use of a placebo control group.
Cleophas TJ, Van der Meulen J, Kalmansohn RB. Cleophas TJ, et al. Int J Clin Pharmacol Ther. 1997 Feb;35(2):47-50. Int J Clin Pharmacol Ther. 1997. PMID: 9147706 Review.
Severe cutaneous adverse drug reactions.
Chung WH, Wang CW, Dao RL. Chung WH, et al. J Dermatol. 2016 Jul;43(7):758-66. doi: 10.1111/1346-8138.13430. Epub 2016 May 6. J Dermatol. 2016. PMID: 27154258 Review.

See all similar articles

References

1. Grover S. Severe cutaneous adverse reactions. Indian J Dermatol Venereol Leprol. 2011;77:3–6. - PubMed
1. Sasidharanpillai S, Ajithkumar K, Jishna P, Khader A, Anagha KV, Binitha MP, et al. RegiSCAR DRESS (drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese consensus group criteria for atypical drug induced hypersensitivity syndrome (DiHS): A comparative analysis. Indian Dermatol Online J. 2022:13. - PMC - PubMed
1. Kim DH, Koh YI. Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome. Allergy Asthma Immunol Res. 2014;3:216–21. - PMC - PubMed
1. Jeremic I, Ostojic P. Possible DRESS syndrome in a patient with systemic sclerosis and rheumatoid arthritis during treatment with lamotrigine. Arch Med. 2018;10:1–3.
1. Yang S-C, Chen C-B, Lin M-Y, Zhang Z-Y, Jia X-Y, Huang M, et al. Genetics of severe cutaneous adverse reactions. Front Med (Lausanne) 2021;8:652091. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources